Reproductive Issues

Methotrexate and Misoprostol Used to Terminate Early Pregnancy

Published in Women's Health Weekly, September 11th, 1995

A recent study published in the New England Journal of Medicine reports on the efficacy of one injectable dose of methotrexate followed by an intravaginal dose of misoprostol to pharmaceutically terminate early pregnancies.

Richard U. Hausknecht reported on the results of his study which included 178 women seeking to terminate pregnancies of less than 63 days ("Methotrexate and Misoprostol to Terminate Early Pregnancy," New England Journal of Medicine, August 31, 1995;333(9):537-40).

According to information provided by the Reproductive Health Technologies project, a non-profit organization based in Washington, D.C., "methotrexate is a folic acid...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1995-09-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry